Recall Register

Food, drugs, devices › Abbott Point Of Care Inc.

Device recall: i-Stat PT/INR Cartridges List number 03P89-24 The cartridges are packaged in sealed pouches, one per pouch. There are 24

FDA enforcement event 71665 · Class II · initiated 15 Jun 2015 · status Terminated · terminated 19 Feb 2016

DeviceVoluntary: Firm initiated1 product recordPrinceton, NJ

Abbott Point Of Care Inc. (Princeton, NJ) initiated this device recall on 15 Jun 2015; FDA lists 1 product record under event 71665, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 19 Feb 2016. Initiation: voluntary: firm initiated. Abbott Point Of Care Inc. has 18 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Abbott Point Of Care Inc., Princeton, NJ.

Reason for recall

"Certain lots of PT/INR cartridges may generate a higher than typical number of PT/INR star outs potentially delaying the generation of patient results for PT/INR."

Distribution

"Worldwide Distribution - US (nationwide) and Internationally to China, Lebanon, Costa Rica, Singapore, Brazil, Jordan, Russia, Greece, Austria, India, Nigeria, United Kingdom, Korea, Saudi Arabia,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2361-2015i-Stat PT/INR Cartridges List number 03P89-24 The cartridges are packaged in sealed pouches, one per pouch. There are 24 cartridges packed in a box. a prothrombin time test useful in monitoring patients receiving oral anticoagulation therapy such as coumadin or warfarin.423,168 cartridgesClass IITerminated19 Aug 2015

Context

91%of 2015 device events are Class II1,153 events that year
1product record in this eventfirm median: 1
18events on this register for the firm

Other enforcement events for Abbott Point Of Care Inc.

InitiatedProduct (first record)TypeClassRecords
1 Apr 2026i-STAT EG7+ cartridge; List Number: 03P76-25;DeviceClass II3
21 Aug 2025i-STAT CG4+ cartridge (white). List Number: 03P85-25.DeviceClass II1
21 Aug 2025i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300DeviceClass II3
22 Dec 2020Abbott i-STAT CG8+ cartridges - IVD Intended for quantitative measurement of sodium, potassium, ionized calcium, glucoseDeviceClass II2
15 Jan 2020i-STAT CHEM8+ cartridges (blue), List No. 09P31-25. UDI (01) 00054749001910 - Product Usage: The i-STAT CHEM8+ cartridgeDeviceClass II2
14 Jan 2020i-STAT G3+ cartridge (blue), List No. 03P78-50, UDI (01) 00054749002283 - Product Usage: The i-STAT G3+ cartridge may beDeviceClass II1
16 Oct 2019i-STAT cTnI cartridgeDeviceClass II1
13 Sep 2018Abbott i-STAT CG8+ Cartridges intended for use in the in vitro quantification of potassium in arterial, venous, or capilDeviceClass II1
12 Sep 2017i-STAT DE handheld data processing module for clinical use, Software Version 2.8, List Number:08K46-01115200 (UDI: 00054DeviceClass II1
1 Jan 2014i-STAT G3+ Cartridge pH, pCO2 and pO2 measurements are used in the diagnosis, monitoring and treatment of respiratory diDeviceClass II1

All 18 events for Abbott Point Of Care Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Certain lots of PT/INR cartridges may generate a higher than typical number of PT/INR star outs potentially delaying the generation of patient results for PT/INR."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US (nationwide) and Internationally to China, Lebanon, Costa Rica, Singapore, Brazil, Jordan, Russia, Greece, Austria, India, Nigeria, United Kingdom, Korea, Saudi Arabia,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 19 Feb 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.